Effects of Heavy Back-Squat PAPE on Jump and Repeated Sprint Performance in Trained Soccer Players
29 luglio 2026 aggiornato da: Abdullah Demirli, Istanbul University - Cerrahpasa
The PAPE Paradox During Prolonged Repeated Sprint Performance: Acute Heavy Back-Squat Potentiates Vertical Jump and Early Sprint Performance But Impairs Overall Output-A Randomized Crossover Trial in Trained Soccer Players
This study examined whether performing heavy back squats before exercise affects jumping ability and repeated sprint performance in trained soccer players.
Twenty male university soccer players completed two testing sessions in a randomized crossover design.
In one session, participants performed a standardized warm-up only.
In the other session, they performed the same warm-up followed by three sets of three back-squat repetitions at 90% of their one-repetition maximum.
The two sessions were separated by one week.
After each condition, participants completed a countermovement jump test and an 18 × 40-meter repeated sprint test.
The study aimed to determine whether the heavy back-squat activity improves early explosive performance and whether it increases fatigue during prolonged repeated sprint exercise.
Panoramica dello studio
Stato
Completato
Condizioni
Intervento / Trattamento
Tipo di studio
Interventistico
Iscrizione (Effettivo)
20
Fase
- Non applicabile
Contatti e Sedi
Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.
Luoghi di studio
-
-
Istanbul
-
Istanbul, Istanbul, Turchia (Türkiye), 34320
- İstanbul University Cerrahpaşa
-
-
Criteri di partecipazione
I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.
Criteri di ammissibilità
Età idonea allo studio
- Adulto
Accetta volontari sani
Sì
Descrizione
Inclusion Criteria:
- Male soccer players aged 20-23 years.
- Currently competing in the top division of a university soccer league.
- A minimum of three years of regular soccer training experience.
- Free from long-term musculoskeletal injury during the previous six months.
- Willing and able to complete all familiarization, strength-testing, and experimental sessions.
- Provision of written informed consent.
Exclusion Criteria:
- A musculoskeletal injury resulting in an absence from training or competition for 21 days or longer during the previous six months.
- Use of medications or nutritional or ergogenic supplements that could affect exercise performance.
- Any health or physical condition preventing safe participation in heavy back-squat, countermovement jump, or repeated sprint testing.
- Failure to complete both experimental conditions.
Piano di studio
Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Scienza basilare
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione incrociata
- Mascheramento: Separare
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Sperimentale: Control-PAPE Sequence
Participants first completed the Control condition, consisting of a standardized warm-up without an additional conditioning activity.
After a one-week washout period, participants completed the PAPE condition, consisting of the same standardized warm-up followed by three sets of three back-squat repetitions at 90% of one-repetition maximum, with 3 minutes of passive recovery between sets.
Countermovement jump and repeated sprint performance were assessed after each condition.
|
Participants completed a standardized warm-up followed by a heavy back-squat conditioning activity consisting of three sets of three repetitions at 90% of one-repetition maximum.
Three minutes of passive recovery were provided between sets.
Countermovement jump performance was assessed approximately 4.5-5 minutes after the final squat set, immediately before the repeated sprint test.
Participants completed a standardized warm-up consisting of 5 minutes of jogging, followed by 10 bodyweight squats, 10 lunges, and 10 lateral shuffles.
No additional conditioning activity was performed.
After approximately 5 minutes of passive recovery, countermovement jump performance was assessed immediately before the repeated sprint test.
|
|
Sperimentale: PAPE-Control Sequence
Participants first completed the PAPE condition, consisting of a standardized warm-up followed by three sets of three back-squat repetitions at 90% of one-repetition maximum, with 3 minutes of passive recovery between sets.
After a one-week washout period, participants completed the Control condition, consisting of the same standardized warm-up without an additional conditioning activity.
Countermovement jump and repeated sprint performance were assessed after each condition.
|
Participants completed a standardized warm-up followed by a heavy back-squat conditioning activity consisting of three sets of three repetitions at 90% of one-repetition maximum.
Three minutes of passive recovery were provided between sets.
Countermovement jump performance was assessed approximately 4.5-5 minutes after the final squat set, immediately before the repeated sprint test.
Participants completed a standardized warm-up consisting of 5 minutes of jogging, followed by 10 bodyweight squats, 10 lunges, and 10 lateral shuffles.
No additional conditioning activity was performed.
After approximately 5 minutes of passive recovery, countermovement jump performance was assessed immediately before the repeated sprint test.
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Repeated Sprint Performance Decrement
Lasso di tempo: During the 18 × 40-meter repeated sprint test, which lasted approximately 15 minutes and was completed within each of two experimental sessions lasting approximately 25-35 minutes; the sessions were separated by a 1-week washout period.
|
Percentage decline in repeated sprint performance calculated from sprint times recorded during an 18 × 40-meter shuttle sprint test.
The protocol consisted of three sets of six 40-meter shuttle sprints, with 20 seconds of passive recovery between sprints and 4 minutes of passive recovery between sets.
Lower percentage values indicate better maintenance of sprint performance and less fatigue.
|
During the 18 × 40-meter repeated sprint test, which lasted approximately 15 minutes and was completed within each of two experimental sessions lasting approximately 25-35 minutes; the sessions were separated by a 1-week washout period.
|
|
Countermovement Jump Height
Lasso di tempo: At approximately 5 minutes after the assigned condition, within each of two experimental sessions lasting approximately 25-35 minutes; the sessions were separated by a 1-week washout period.
|
Maximum countermovement jump height measured in centimeters using the Optojump Next optical measurement system.
Participants performed three maximal countermovement jump trials with their hands positioned on their hips and 60 seconds of passive recovery between trials.
The highest jump height was used for analysis.
Higher values indicate better jump performance.
|
At approximately 5 minutes after the assigned condition, within each of two experimental sessions lasting approximately 25-35 minutes; the sessions were separated by a 1-week washout period.
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Mean Repeated Sprint Time
Lasso di tempo: During the 18 × 40-meter repeated sprint test, which lasted approximately 15 minutes and was completed within each of two experimental sessions lasting approximately 25-35 minutes; the sessions were separated by a 1-week washout period.
|
Mean sprint time, measured in seconds, calculated across all 18 repetitions of the 40-meter shuttle sprint test.
Sprint times were recorded using a photocell timing system.
Lower values indicate better repeated sprint performance.
|
During the 18 × 40-meter repeated sprint test, which lasted approximately 15 minutes and was completed within each of two experimental sessions lasting approximately 25-35 minutes; the sessions were separated by a 1-week washout period.
|
|
Best Sprint Time
Lasso di tempo: During the 18 × 40-meter repeated sprint test, which lasted approximately 15 minutes and was completed within each of two experimental sessions lasting approximately 25-35 minutes; the sessions were separated by a 1-week washout period.
|
The fastest sprint time, measured in seconds, recorded among the 18 repetitions of the 40-meter shuttle sprint test using a photocell timing system.
Lower values indicate better sprint performance.
|
During the 18 × 40-meter repeated sprint test, which lasted approximately 15 minutes and was completed within each of two experimental sessions lasting approximately 25-35 minutes; the sessions were separated by a 1-week washout period.
|
|
Worst Sprint Time
Lasso di tempo: During the 18 × 40-meter repeated sprint test, which lasted approximately 15 minutes and was completed within each of two experimental sessions lasting approximately 25-35 minutes; the sessions were separated by a 1-week washout period.
|
The slowest sprint time, measured in seconds, recorded among the 18 repetitions of the 40-meter shuttle sprint test using a photocell timing system.
Lower values indicate better sprint performance.
|
During the 18 × 40-meter repeated sprint test, which lasted approximately 15 minutes and was completed within each of two experimental sessions lasting approximately 25-35 minutes; the sessions were separated by a 1-week washout period.
|
|
Sprint Time Across Individual Repetitions
Lasso di tempo: During each repetition of the 18 × 40-meter repeated sprint test, which lasted approximately 15 minutes and was completed within each of two experimental sessions lasting approximately 25-35 minutes; the sessions were separated by a 1-week washout period
|
Sprint time, measured in seconds, for each of the 18 individual 40-meter shuttle sprint repetitions.
Sprint-by-sprint values were used to evaluate changes in performance during the early repetitions (sprints 1-3), middle repetitions (sprints 4-8), and later repetitions (sprints 9-18).
Lower values indicate faster sprint performance.
|
During each repetition of the 18 × 40-meter repeated sprint test, which lasted approximately 15 minutes and was completed within each of two experimental sessions lasting approximately 25-35 minutes; the sessions were separated by a 1-week washout period
|
Collaboratori e investigatori
Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.
Sponsor
Studiare le date dei record
Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.
Studia le date principali
Inizio studio (Effettivo)
20 dicembre 2025
Completamento primario (Effettivo)
15 febbraio 2026
Completamento dello studio (Effettivo)
15 febbraio 2026
Date di iscrizione allo studio
Primo inviato
26 luglio 2026
Primo inviato che soddisfa i criteri di controllo qualità
29 luglio 2026
Primo Inserito (Effettivo)
30 luglio 2026
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
30 luglio 2026
Ultimo aggiornamento inviato che soddisfa i criteri QC
29 luglio 2026
Ultimo verificato
1 luglio 2026
Maggiori informazioni
Termini relativi a questo studio
Altri numeri di identificazione dello studio
- PAPE-RSA-2025-01
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
NO
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
No
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
No
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .